Bifidobacteria—Insight into clinical outcomes and mechanisms of its probiotic action
Open accessThe DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bifidobacteria can protect from enteropathogenic infection through production of acetate
Fukuda, S., Toh, H., Hase, K., Oshima, K., Nakanishi, Y., Yoshimura, K., Tobe, T., Clarke, J. M., Topping, D. L., Suzuki, T., et al. (2011) · Nature · doi:10.1038/nature09646 · Cited by 2,387
Intestinal barrier function: molecular regulation and disease pathogenesis
Groschwitz, K. R., & Hogan, S. P. (2009) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.05.038 · Cited by 1,775 · cited 1×
“Breakdown of probiotic barrier against pathogens often leads to gastrointestinal problems such as gastroenteritis, enterocolitis, irritable bowel syndrome (IBS), diarrhoea and food allergies/intolerances (Bermudez-Brito et al. 2012; Guglielmetti et al. 2011; Groschwitz and Hogan 2009).”
O’Mahony, L., McCarthy, J., Kelly, P., Hurley, G., Luo, F., Chen, K., O’Sullivan, G. C., Kiely, B., Collins, J. K., Shanahan, F., et al. (2005) · Gastroenterology · doi:10.1053/j.gastro.2004.11.050 · Cited by 1,448
Regulation of Tight Junction Permeability by Intestinal Bacteria and Dietary Components1,2
Ulluwishewa, D., Anderson, R. C., McNabb, W. C., Moughan, P. J., Wells, J. M., & Roy, N. C. (2011) · The Journal of Nutrition · doi:10.3945/jn.110.135657 · Cited by 1,177
Host interactions of probiotic bacterial surface molecules: comparison with commensals and pathogens
Lebeer, S., Vanderleyden, J., & De Keersmaecker, S. C. J. (2010) · Nature Reviews Microbiology · doi:10.1038/nrmicro2297 · Cited by 1,062
Probiotic use in clinical practice: what are the risks?
Boyle, R. J., Robins-Browne, R. M., & Tang, M. L. (2006) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/83.6.1256 · Cited by 776 · cited 1×
“…species from gastrointestinal to extraintestinal sites, their bloodstream survival, mucin degradation activity and possible infectivity should be considered carefully prior to its administration, especially to patients with challenged immune systems (Borriello et al 2003; Boyle et al 2006).”
Akkasheh, G., Kashani-Poor, Z., Tajabadi-Ebrahimi, M., Jafari, P., Akbari, H., Taghizadeh, M., Memarzadeh, M. R., Asemi, Z., & Esmaillzadeh, A. (2016) · Nutrition · doi:10.1016/j.nut.2015.09.003 · Cited by 767
Diversity of Bifidobacteria within the Infant Gut Microbiota
Turroni, F., Peano, C., Pass, D. A., Foroni, E., Severgnini, M., Claesson, M. J., Kerr, C., Hourihane, J., Murray, D., Fuligni, F., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036957 · Cited by 647 · cited 1×
“Bifidobacterial flora in neonatal gut is established within the first few days after delivery and constitutes upto almost 80% of the microfloral composition during infancy (Turroni et al. 2012).”
Review article: bifidobacteria as probiotic agents – physiological effects and clinical benefits
PICARD, C., FIORAMONTI, J., FRANCOIS, A., ROBINSON, T., NEANT, F., & MATUCHANSKY, C. (2005) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2005.02615.x · Cited by 618 · cited 1×
“While B. animalis DN-173010 is particularly found to be helpful in improving faecal colonic transit time in people with long transit times (Picard et al. 2005).”
Laboratory evolution of copper tolerant yeast strains
Adamo, G. M., Brocca, S., Passolunghi, S., Salvato, B., & Lotti, M. (2012) · Microbial Cell Factories · doi:10.1186/1475-2859-11-1 · Cited by 392
O'Connell Motherway, M., Zomer, A., Leahy, S. C., Reunanen, J., Bottacini, F., Claesson, M. J., O'Brien, F., Flynn, K., Casey, P. G., Moreno Munoz, J. A., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1105380108 · Cited by 376
Shen, J., Zuo, Z.-X., & Mao, A.-P. (2014) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000437495.30052.be · Cited by 364 · cited 1×
“Bifidobacteria is also reported to exhibit probiotic effects against Crohn’s disease, ulcerative colitis and pouchitis (Shen et al. 2014; Tamaki et al. 2015; Saez-Lara et al. 2015).”
Seasonal Variation in Human Gut Microbiome Composition
Davenport, E. R., Mizrahi-Man, O., Michelini, K., Barreiro, L. B., Ober, C., & Gilad, Y. (2014) · PLoS ONE · doi:10.1371/journal.pone.0090731 · Cited by 314
Roger, L. C., Costabile, A., Holland, D. T., Hoyles, L., & McCartney, A. L. (2010) · Microbiology · doi:10.1099/mic.0.043224-0 · Cited by 291
Guglielmetti, S., Mora, D., Gschwender, M., & Popp, K. (2011) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2011.04633.x · Cited by 287 · cited 2×
“Clinical study shows that administration of B. bifidum MIMBb75 strain as nutritional supplement could substantially relieve patients of IBS symptoms and promote a healthy life compared to those on placebo (Guglielmetti et al 2011).”
Chichlowski, M., De Lartigue, G., German, J. B., Raybould, H. E., & Mills, D. A. (2012) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0b013e31824fb899 · Cited by 276 · cited 2×
“Prebiotics often assists the competitive exclusion of enteric pathogen by competing for pathogen binding sites (Becerra et al. 2015; Chichlowski et al. 2012).”
Tamaki, H., Nakase, H., Inoue, S., Kawanami, C., Itani, T., Ohana, M., Kusaka, T., Uose, S., Hisatsune, H., Tojo, M., et al. (2016) · Digestive Endoscopy · doi:10.1111/den.12553 · Cited by 214
Demers, M., Dagnault, A., & Desjardins, J. (2014) · Clinical Nutrition · doi:10.1016/j.clnu.2013.10.015 · Cited by 209
Izzo, N. J., Staniszewski, A., To, L., Fa, M., Teich, A. F., Saeed, F., Wostein, H., Walko, T., Vaswani, A., Wardius, M., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0111898 · Cited by 180
Sugahara, H., Odamaki, T., Fukuda, S., Kato, T., Xiao, J.-Z., Abe, F., Kikuchi, J., & Ohno, H. (2015) · Scientific Reports · doi:10.1038/srep13548 · Cited by 169 · cited 2×
“SCFA includes lactates, formats, acetates, propionates, butyrates and pimelates (Asarat et al. 2015; Sugahara et al. 2015; Tabasco et al. 2014).”
Enomoto, T., Sowa, M., Nishimori, K., Shimazu, S., Yoshida, A., Yamada, K., Furukawa, F., Nakagawa, T., Yanagisawa, N., Iwabuchi, N., et al. (2014) · Allergology International · doi:10.2332/allergolint.13-oa-0683 · Cited by 165 · cited 1×
“…atopic diseases is well established, with B. breve LMG 23729, B. longum BB536, B. lactis Bb-12 being some of the strains with reported efficacy (Enomoto et al. 2014; Meneghin et al. 2012), while B. lactis NCC 2818 is reported to alleviate symptoms of seasonal allergic rhinitis (Singh et al.…”
Toiviainen, A., Jalasvuori, H., Lahti, E., Gursoy, U., Salminen, S., Fontana, M., Flannagan, S., Eckert, G., Kokaras, A., Paster, B., et al. (2015) · Clinical Oral Investigations · doi:10.1007/s00784-014-1221-6 · Cited by 140 · cited 2×
“…of oral plaque and improvement of symptoms related to depressive disorders and Schizophrenia (Akkasheh et al. 2015; Minami et al. 2015; Nishihira et al. 2014; Toiviainen et al. 2015; Tomasik et al. 2015; Myhre et al. 2011) are some of the numerous beneficial effects offered by bifidobacteria.”
Implication of an Outer Surface Lipoprotein in Adhesion of Bifidobacterium bifidum to Caco-2 Cells
Guglielmetti, S., Tamagnini, I., Mora, D., Minuzzo, M., Scarafoni, A., Arioli, S., Hellman, J., Karp, M., & Parini, C. (2008) · Applied and Environmental Microbiology · doi:10.1128/aem.00124-08 · Cited by 128 · cited 2×
“Studies indicate strain specific interplay of lectins, lipoproteins, adhesion molecules, pili/appendages or exopolysaccharides assisted multifactorial binding to the gut mucosa (Gleinser et al. 2012; Guglielmetti et al. 2008; Kavanaugh et al. 2013; Roger et al. 2010).”
Bacteriocins: Recent trends and potential applications
Bali, V., Panesar, P. S., Bera, M. B., & Kennedy, J. F. (2016) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2012.729231 · Cited by 119
Presti, I., D’Orazio, G., Labra, M., La Ferla, B., Mezzasalma, V., Bizzaro, G., Giardina, S., Michelotti, A., Tursi, F., Vassallo, M., et al. (2015) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-015-6482-8 · Cited by 118
Bile Affects the Synthesis of Exopolysaccharides by Bifidobacterium animalis
Ruas-Madiedo, P., Gueimonde, M., Arigoni, F., de los Reyes-Gavilán, C. G., & Margolles, A. (2009) · Applied and Environmental Microbiology · doi:10.1128/aem.00908-08 · Cited by 103 · cited 1×
“In this regard, works by Ruas-Madiedo, Reyes-Gavilán and Sinderen are particularly noteworthy (Fanning et al. 2012; Hidalgo-Cantabrana et al. 2013 and 2014; Ruas-Madiedo et al. 2009; Salazar et al. 2008).”
Singh, A., Hacini-Rachinel, F., Gosoniu, M. L., Bourdeau, T., Holvoet, S., Doucet-Ladeveze, R., Beaumont, M., Mercenier, A., & Nutten, S. (2013) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2012.197 · Cited by 93 · cited 2×
“The probiotic microorganism mitigates immune parameters and lowers Th2 cytokine levels (Singh et al. 2013).”
Meng, H., Ba, Z., Lee, Y., Peng, J., Lin, J., Fleming, J. A., Furumoto, E. J., Roberts, R. F., Kris-Etherton, P. M., & Rogers, C. J. (2017) · European Journal of Nutrition · doi:10.1007/s00394-015-1109-5 · Cited by 52
Li, C.-Y., Lin, H.-C., Lai, C.-H., Lu, J. J.-Y., Wu, S.-F., & Fang, S.-H. (2011) · International Archives of Allergy and Immunology · doi:10.1159/000322350 · Cited by 37
Cited by
Health Benefits of Heat-Killed (Tyndallized) Probiotics: An Overview
Piqué, N., Berlanga, M., & Miñana-Galbis, D. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20102534 · Cited by 642
Xu, Y., Cui, Y., Yue, F., Liu, L., Shan, Y., Liu, B., Zhou, Y., & Lü, X. (2019) · Food Hydrocolloids · doi:10.1016/j.foodhyd.2019.03.032 · Cited by 189
Hungin, A. P. S., Mitchell, C. R., Whorwell, P., Mulligan, C., Cole, O., Agréus, L., Fracasso, P., Lionis, C., Mendive, J., Philippart de Foy, J. ‐., et al. (2018) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.14539 · Cited by 154
Dendritic cell–derived hepcidin sequesters iron from the microbiota to promote mucosal healing
Bessman, N. J., Mathieu, J. R. R., Renassia, C., Zhou, L., Fung, T. C., Fernandez, K. C., Austin, C., Moeller, J. B., Zumerle, S., Louis, S., et al. (2020) · Science · doi:10.1126/science.aau6481 · Cited by 145
“Notably, Bifidobacteria supports epithelial barrier function, and dietary iron supplementation can suppress Bifidobacteria and exacerbate inflammation (20).”
BackgroundLe Barz, M., Daniel, N., Varin, T. V., Naimi, S., Demers‐Mathieu, V., Pilon, G., Audy, J., Laurin, É., Roy, D., Urdaci, M. C., et al. (2019) · The FASEB Journal · doi:10.1096/fj.201801672r · Cited by 63
Metadata
- Authors
- Sarkar, A., & Mandal, S.
- Venue
- Microbiological Research
- Publisher
- Elsevier BV
- Published
- 2016-11
- Volume
- 192
- Pages
- 159-171
- ISSN
- 0944-5013 (ISSN-L)
- OpenAlex
- W2464484550
- Cited by
- 179
- References
- 29
- FWCI
- 17.63
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.